Treatments with verteporfin (VP) and dienogest have been shown to downregulate miR-21-5p and YAP1 expression, leading to upregulation of PR expression, thus improving progesterone resistance in endometriosis in humans and mouse models [98]. This evidence concerns the gene PGR and endometriosis.